Veltuzumab
Product Specifications
UNSPSC Description
Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody. Veltuzumab has low EC50 value of 0.08-0.09 μg/mL in the Daudi cell line. Veltuzumab can be used for the research of cancer including non-Hodgkin lymphoma (NHL)[1].
Target Antigen
Integrin
Type
Inhibitory Antibodies
Related Pathways
Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/veltuzumab.html
Purity
99.69
Solubility
10 mM in DMSO
Smiles
[Veltuzumab]
References & Citations
[1]David M Goldenberg, et al. Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody. Blood
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99224/Veltuzumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99224/Veltuzumab-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
728917-18-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS9422234-01 0.02 mg
Recombinant Human Carcinoembryonic antigen-related cell adhesion molecule 4
Ask
View Details MBS9422234-02 0.1 mg
Recombinant Human Carcinoembryonic antigen-related cell adhesion molecule 4
Ask
View Details